EE03105B1 - Farmakoloogilist ioniseeruvat toimeainet sisaldavad ravimvormid ja nende valmistamise protsess - Google Patents
Farmakoloogilist ioniseeruvat toimeainet sisaldavad ravimvormid ja nende valmistamise protsessInfo
- Publication number
- EE03105B1 EE03105B1 EE9400416A EE9400416A EE03105B1 EE 03105 B1 EE03105 B1 EE 03105B1 EE 9400416 A EE9400416 A EE 9400416A EE 9400416 A EE9400416 A EE 9400416A EE 03105 B1 EE03105 B1 EE 03105B1
- Authority
- EE
- Estonia
- Prior art keywords
- preparation
- pharmacologically
- active ingredient
- formulations containing
- ionizable active
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
- A61K47/585—Ion exchange resins, e.g. polystyrene sulfonic acid resin
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Saccharide Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9003903A SE9003903D0 (sv) | 1990-12-07 | 1990-12-07 | New pharmaceutical formulations |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EE03105B1 true EE03105B1 (et) | 1998-08-17 |
Family
ID=20381122
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EE9400416A EE03105B1 (et) | 1990-12-07 | 1994-11-17 | Farmakoloogilist ioniseeruvat toimeainet sisaldavad ravimvormid ja nende valmistamise protsess |
Country Status (17)
| Country | Link |
|---|---|
| US (2) | US5707656A (et) |
| EP (1) | EP0560816B1 (et) |
| JP (1) | JP3276956B2 (et) |
| AT (1) | ATE444737T1 (et) |
| AU (1) | AU656346B2 (et) |
| CA (1) | CA2097176C (et) |
| DE (1) | DE69133623D1 (et) |
| EE (1) | EE03105B1 (et) |
| FI (1) | FI932553A (et) |
| HU (1) | HU218661B (et) |
| IE (1) | IE914136A1 (et) |
| IS (1) | IS1749B (et) |
| NO (1) | NO305536B1 (et) |
| PT (1) | PT99720B (et) |
| SE (1) | SE9003903D0 (et) |
| WO (1) | WO1992010171A1 (et) |
| YU (1) | YU186791A (et) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1998027961A2 (en) * | 1996-12-20 | 1998-07-02 | Warner Lambert Company | Antitussive drugs delivered by partially coated ion exchange resins |
| US20030118641A1 (en) * | 2000-07-27 | 2003-06-26 | Roxane Laboratories, Inc. | Abuse-resistant sustained-release opioid formulation |
| EP1204406A2 (en) * | 1999-07-29 | 2002-05-15 | Roxane Laboratories, Inc. | Opioid sustained-released formulation |
| EP1414458B1 (en) * | 2001-07-06 | 2007-04-11 | Endo Pharmaceuticals Inc. | Oral administration of 6-hydroxy-oxymorphone for use as an analgesic |
| US20030099711A1 (en) * | 2001-08-29 | 2003-05-29 | David Meadows | Sustained release preparations |
| CA2481091A1 (en) * | 2002-04-05 | 2003-10-23 | Penwest Pharmaceuticals Co. | Sustained release metoprolol formulations |
| US7314640B2 (en) * | 2003-07-11 | 2008-01-01 | Mongkol Sriwongjanya | Formulation and process for drug loaded cores |
| US20050265955A1 (en) * | 2004-05-28 | 2005-12-01 | Mallinckrodt Inc. | Sustained release preparations |
| JP2006296511A (ja) * | 2005-04-15 | 2006-11-02 | Transcutaneous Technologies Inc | 外用剤、外用剤の塗布方法、イオントフォレーシス装置及び経皮パッチ |
| JP2006346368A (ja) * | 2005-06-20 | 2006-12-28 | Transcutaneous Technologies Inc | イオントフォレーシス装置及びその製造方法 |
| EP1905433A1 (en) * | 2005-07-15 | 2008-04-02 | Transcu Ltd. | Percutaneous absorption patch with application position indicating function, and iontophoresis device |
| JP2007037868A (ja) * | 2005-08-05 | 2007-02-15 | Transcutaneous Technologies Inc | 経皮投与装置及びその制御方法 |
| US8386030B2 (en) * | 2005-08-08 | 2013-02-26 | Tti Ellebeau, Inc. | Iontophoresis device |
| US20070060860A1 (en) * | 2005-08-18 | 2007-03-15 | Transcutaneous Technologies Inc. | Iontophoresis device |
| JPWO2007026671A1 (ja) * | 2005-08-29 | 2009-03-05 | Ｔｔｉ・エルビュー株式会社 | センサからの情報により投与すべき薬剤の選定を行うイオントフォレーシス装置 |
| NZ566628A (en) * | 2005-09-16 | 2010-02-26 | Tti Ellebeau Inc | Catheter type iontophoresis apparatus using alternating layers of electrolytes and ion exchange membranes |
| US20070071807A1 (en) * | 2005-09-28 | 2007-03-29 | Hidero Akiyama | Capsule-type drug-releasing device and capsule-type drug-releasing device system |
| WO2007038028A1 (en) * | 2005-09-28 | 2007-04-05 | Tti Ellebeau, Inc. | Iontophoresis apparatus and method to deliver active agents to biological interfaces |
| WO2007037476A1 (ja) * | 2005-09-30 | 2007-04-05 | Tti Ellebeau, Inc. | 睡眠導入剤と興奮剤の投与量および投与時期を制御するイオントフォレーシス装置 |
| CA2622777A1 (en) * | 2005-09-30 | 2007-04-12 | Tti Ellebeau, Inc. | Iontophoresis device to deliver multiple active agents to biological interfaces |
| WO2007037475A1 (ja) * | 2005-09-30 | 2007-04-05 | Tti Ellebeau, Inc. | 形状記憶セパレータを有するイオントフォレーシス用電極構造体およびそれを用いたイオントフォレーシス装置 |
| US20070197955A1 (en) * | 2005-10-12 | 2007-08-23 | Transcutaneous Technologies Inc. | Mucous membrane adhesion-type iontophoresis device |
| US20080193514A1 (en) * | 2006-11-02 | 2008-08-14 | Transcu Ltd. | Compostions and methods for iontophoresis delivery of active ingredients through hair follicles |
| JPWO2008087803A1 (ja) * | 2007-01-16 | 2010-05-06 | 国立大学法人北海道大学 | 抗酸化成分を封入したイオントフォレーシス用リポソーム製剤 |
| JP2010187707A (ja) * | 2007-06-12 | 2010-09-02 | Hokkaido Univ | インスリンを封入したイオントフォレーシス用リポソーム製剤 |
| AU2009291764A1 (en) * | 2008-09-10 | 2010-03-18 | Transcu Ltd. | Apparatus and method to dispense HPC-based viscous liquids into porous substrates, e.g., continuous web-based process |
| CA2757337A1 (en) | 2009-04-03 | 2010-10-07 | Coating Place, Inc. | Modified-release pharmaceutical drug composition |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4983392A (en) * | 1983-11-14 | 1991-01-08 | Bio-Mimetics, Inc. | Bioadhesive compositions and methods of treatment therewith |
| US4692462A (en) * | 1985-03-18 | 1987-09-08 | Menley & James Laboratories, Ltd. | Compositions and method of controlling transdermal penetration of topical and systemic agents |
| EP0199855A1 (en) * | 1985-05-02 | 1986-11-05 | Gist-Brocades N.V. | Tablets comprising tromethoprim and a sulfonamide |
| JPS62223112A (ja) * | 1986-03-25 | 1987-10-01 | Rooto Seiyaku Kk | 歯周病治療剤 |
| IE62100B1 (en) * | 1986-07-30 | 1994-12-14 | Fisons Corp | Coated ion exchange resins |
| DE3740684A1 (de) * | 1987-12-01 | 1989-06-15 | Woehr Otto Gmbh | Parksystem |
| MC2025A1 (fr) * | 1988-04-20 | 1990-04-25 | Asta Pharma Ag | Medicament contenant de l'azelastine et capable de liberer celle-ci de facon controlee |
| IL90245A (en) * | 1988-05-11 | 1994-04-12 | Glaxo Group Ltd | Resin adsorption containing ranitidine together with synthetic resin replaces cations, its preparation and pharmaceutical preparations containing it |
| CA2002492A1 (en) * | 1988-11-11 | 1990-05-11 | Sandra T. A. Malkowska | Pharmaceutical ion exchange resin composition |
| US5149523A (en) * | 1989-06-20 | 1992-09-22 | Aktiebolaget Hassle | Polystyrenesulfonate-drug complex and solid dosage forms thereof |
-
1990
- 1990-12-07 SE SE9003903A patent/SE9003903D0/xx unknown
-
1991
- 1991-11-27 YU YU186791A patent/YU186791A/sh unknown
- 1991-11-28 IE IE413691A patent/IE914136A1/en not_active Application Discontinuation
- 1991-12-03 EP EP91920634A patent/EP0560816B1/en not_active Expired - Lifetime
- 1991-12-03 CA CA002097176A patent/CA2097176C/en not_active Expired - Fee Related
- 1991-12-03 HU HU9301671A patent/HU218661B/hu not_active IP Right Cessation
- 1991-12-03 AT AT91920634T patent/ATE444737T1/de not_active IP Right Cessation
- 1991-12-03 WO PCT/SE1991/000814 patent/WO1992010171A1/en active Application Filing
- 1991-12-03 DE DE69133623T patent/DE69133623D1/de not_active Expired - Fee Related
- 1991-12-03 AU AU89305/91A patent/AU656346B2/en not_active Ceased
- 1991-12-03 JP JP50011692A patent/JP3276956B2/ja not_active Expired - Fee Related
- 1991-12-04 US US07/802,325 patent/US5707656A/en not_active Expired - Lifetime
- 1991-12-06 IS IS3787A patent/IS1749B/is unknown
- 1991-12-06 PT PT99720A patent/PT99720B/pt active IP Right Grant
-
1993
- 1993-06-04 NO NO932053A patent/NO305536B1/no not_active IP Right Cessation
- 1993-06-04 FI FI932553A patent/FI932553A/fi unknown
-
1994
- 1994-03-22 US US08/216,028 patent/US5709882A/en not_active Expired - Lifetime
- 1994-11-17 EE EE9400416A patent/EE03105B1/et not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| AU656346B2 (en) | 1995-02-02 |
| HUT64213A (en) | 1993-12-28 |
| DE69133623D1 (de) | 2009-11-19 |
| PT99720B (pt) | 2002-04-29 |
| WO1992010171A1 (en) | 1992-06-25 |
| NO932053D0 (no) | 1993-06-04 |
| PT99720A (pt) | 1992-10-30 |
| EP0560816B1 (en) | 2009-10-07 |
| JPH06503311A (ja) | 1994-04-14 |
| HU9301671D0 (en) | 1993-09-28 |
| NO932053L (no) | 1993-07-20 |
| HU218661B (hu) | 2000-10-28 |
| AU8930591A (en) | 1992-07-08 |
| JP3276956B2 (ja) | 2002-04-22 |
| CA2097176A1 (en) | 1992-06-08 |
| US5709882A (en) | 1998-01-20 |
| IE914136A1 (en) | 1992-06-17 |
| IS1749B (is) | 2000-07-11 |
| YU186791A (sh) | 1994-04-05 |
| ATE444737T1 (de) | 2009-10-15 |
| CA2097176C (en) | 2002-03-26 |
| US5707656A (en) | 1998-01-13 |
| NO305536B1 (no) | 1999-06-21 |
| IS3787A7 (is) | 1992-06-08 |
| FI932553A0 (fi) | 1993-06-04 |
| EP0560816A1 (en) | 1993-09-22 |
| FI932553A (fi) | 1993-06-04 |
| SE9003903D0 (sv) | 1990-12-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EE03105B1 (et) | Farmakoloogilist ioniseeruvat toimeainet sisaldavad ravimvormid ja nende valmistamise protsess | |
| BR9406363A (pt) | Composiçao farmacêutica processo para a preparaçao da mesma uso da mesma e processo para o tratamento de doenças relacionadas com o ácido gástrico | |
| NO851170L (no) | Lagringsstabile, hurtignedbrytende farmasoeytiske virksomme stoff-presslegemer | |
| YU174490A (sh) | Novi estri tienil-karboksilne kiseline sa aminoalkoholima, njihova kvaterna jedinjenja kao i pripremanje i primena tih jedinjenja | |
| PT88404A (pt) | Dosage form comprising fast agent delivery followed by slow agent delivery | |
| ATE95983T1 (de) | Graduelle verabreichungsstrukturen fuer kaugummi. | |
| ATE22535T1 (de) | Pharmazeutische zusammensetzungen fuer die kontinuierliche freigabe des wirkstoffes. | |
| BR0008590A (pt) | Agente de entrega polimérico, composição, formade unidade de dosagem, método para administrarum agente biologicamente ativo a um animalnecessitando o agente, método para preparar umacomposição; e composto | |
| NL193907B (nl) | Basische ether en farmaceutische samenstelling die de basische ether als actief bestanddeel bevat. | |
| HUP9602498A2 (hu) | Antimikrobiális hatású gyógyászati készítmények | |
| ES2173858T3 (es) | Analogos de huperzina a. | |
| DK0957981T3 (da) | Rersorvoirer til aflevering af lægemidler ved elektrotransport, indeholdende inerte fyldmaterialer | |
| DK0727996T3 (da) | Fendazolformuleringer | |
| ATE68686T1 (de) | System zum freigeben von stoffen in der vagina. | |
| ATE42202T1 (de) | Therapeutische zubereitung mit ammoniumnitrat als wirkstoff. | |
| ATE254851T1 (de) | Iod-herstellungszusammensetzung | |
| ES2129893T3 (es) | Dinucleosido-5',5'-pirofosfatos. | |
| DE3862017D1 (de) | Pharmazeutische zubereitung zur behandlung von tinea pedis. | |
| ES2013342A6 (es) | Procedimiento para preparar composiciones farmaceuticas a base de ingredientes seleccionados principalmente entre alcohol, fenol, polvo de cantarida, yodo y fosforo. | |
| DK0450123T3 (da) | Farmaceutisk præparat til topisk administration indeholdende dichlofenac-natrium | |
| SE9902742D0 (sv) | New pharmaceutical formultion | |
| BR9813037A (pt) | Composto, processo para sua preparação, uso do mesmo, preparação farmacêutica, e, combinação desta com pelo menos uma outra substância ativa | |
| IT8720800A0 (it) | Composto attivo nella terapia carciovascolare. | |
| TR22867A (tr) | Birden fazla aktif bilesen ihtiva eden insektisid terkibi | |
| RS49796B (sr) | UPOTREBA SOLI 3α, 7α-DIHIDROKSI-12-KETO-5β-HOLANSKE KISELINE KAO AKTIVNE SUPSTANCE ZA IZRADU LEKOVA ZA LEČENJE DIJABETESA |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| KB4A | Valid patent at the end of a year |
Effective date: 20021231 |
|
| MM4A | Lapsed by not paying the annual fees |
Effective date: 20021117 |